Pure Global AI
NCT06368947Recruiting

Therapeutic Play on Pain Tolerance and Emotion Regulation in Children

Therapeutic Play on Pain Tolerance and Emotion Regulation in Children Receiving Chemotherapy
Ataturk UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Cancer
Drug/Device/Intervention
Therapeutic Play
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Ataturk University
Location
Erzurum, Turkey
Timeline & enrollment
Phase
N/A
Start date
Mar 29, 2024
End date
Dec 29, 2026
Enrollment
66 participants
Primary outcome

Pain Tolerance Scale for Children with Cancer,Emotion Regulation Scale for Children and Adolescents

Summary

The research is a randomized controlled experimental study. The population of the research
 will consist of 10-18 year old children who were diagnosed with acute lymphoblastic leukemia
 and received chemotherapy, who were admitted to the Children's Hematology Clinic of Adana
 City Training and Research Hospital between 19.05.2024 and 19.05.2025. Therapeutic play
 sessions will occur over a 4-week period during chemotherapy treatment.

ICD-10 classifications
Carcinoid syndromeOther chemotherapyCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Prepuce
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06368947
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06368947 through Pure Global AI's free database. This phase not specified trial is sponsored by Ataturk University and is currently Recruiting. The study focuses on Cancer. Target enrollment is 66 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.